Nasopharynx – V9: 2025+
Primary Site | Histology | Year of Diagnosis |
---|---|---|
C110-C113, C118-C119 | 8000-8700 | 2025-9998, 9999, <BLANK> |
Notes
C110-C113, C118-C119: 8000-8700 C110 Superior wall of nasopharynx C111 Posterior wall of nasopharynx (including pharyngeal tonsil) C112 Lateral wall of nasopharynx C113 Anterior wall of nasopharynx C118 Overlapping lesion of nasopharynx C119 Nasopharynx, NOS **Note 1:** **Sources used in the development of this schema** * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * *Nasopharynx*, from the AJCC Cancer Staging System Version 9 (2025). Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** **Other EOD Schemas with Nasopharynx sites** * **GIST**: 8935-8936 * **Kaposi Sarcoma**: 9140 * **Melanoma Head and Neck**: 8720-8790 * **Mycosis Fungoides**: 9700-9701 **Soft Tissue Head and Neck**: 8710-8714, 8800-8803, 8810-8905, 8912, 8921, 8932-8934, 8940-8990, 9000-9016, 9030-9043, 9045-9110, 9121-9138, 9141-9230, 9240-9580, 9582 **Soft Tissue Other**: 8992 **Soft Tissue Rare**: 8804-8806, 8910, 8920, 8930-8931, 8991, 9020, 9044, 9120, 9231, 9581Data Items
Name | Default Value | Used in Derivation | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Year of Diagnosis | Yes |
NAACCR #390
dateOfDiagnosis |
None | ||
Primary Site | Yes |
NAACCR #400
primarySite |
None | ||
Histology | Yes |
NAACCR #522
histologicTypeIcdO3 |
None | ||
Behavior | No |
NAACCR #523
behaviorCodeIcdO3 |
None | ||
Type of Reporting Source | No |
NAACCR #500
typeOfReportingSource |
None | ||
Tumor Size Clinical | No |
NAACCR #752
tumorSizeClinical |
None | ||
Tumor Size Pathological | No |
NAACCR #754
tumorSizePathologic |
None | ||
Tumor Size Summary | 999 | No |
NAACCR #756
tumorSizeSummary |
None | |
Regional Nodes Positive | 99 | No |
NAACCR #820
regionalNodesPositive |
None | |
Regional Nodes Examined | 99 | No |
NAACCR #830
regionalNodesExamined |
None | |
Neoadjuvant Therapy | 9 | No |
NAACCR #1632
neoadjuvantTherapy |
None | |
Neoadjuvant Therapy – Clinical Response | 9 | No |
NAACCR #1633
neoadjuvTherapyClinicalResponse |
None | |
Neoadjuvant Therapy – Treatment Effect | 9 | No |
NAACCR #1634
neoadjuvTherapyTreatmentEffect |
None | |
EOD Primary Tumor | 999 | Yes |
NAACCR #772
eodPrimaryTumor |
None | |
EOD Regional Nodes | 999 | Yes |
NAACCR #774
eodRegionalNodes |
None | |
EOD Mets | 00 | Yes |
NAACCR #776
eodMets |
None | |
SS2018 | No |
NAACCR #764
summaryStage2018 |
None | ||
Grade Clinical | 9 | Yes |
NAACCR #3843
gradeClinical |
All | SSDI |
Grade Pathological | 9 | Yes |
NAACCR #3844
gradePathological |
All | SSDI |
Grade Post Therapy Clin (yc) | No |
NAACCR #1068
gradePostTherapyClin |
COC NPCR SEER |
SSDI | |
Grade Post Therapy Path (yp) | No |
NAACCR #3845
gradePostTherapy |
CCCR/Canada COC NPCR SEER |
SSDI | |
Extranodal Exten H&N Clin | 8 | No |
NAACCR #3831
extranodalExtensionHeadNeckClin |
COC SEER (RC) |
SSDI |
Extranodal Exten H&N Path | X.8 | No |
NAACCR #3832
extranodalExtensionHeadNeckPath |
CCCR/Canada COC SEER 2025–2025 SEER (RC) 2026– |
SSDI |
LN Size | XX.8 | No |
NAACCR #3883
lnSize |
CCCR/Canada COC SEER 2025–2025 SEER (RC) 2026– |
SSDI |
Initial Context
Outputs
Name | Default Value | Description | NAACCR Item | Metadata |
---|---|---|---|---|
Schema ID | 09090 |
NAACCR #3800
schemaId |
None | |
Derived Version | {{ctx_alg_version}} | None | None | |
Derived Summary Stage 2018 | 9 |
NAACCR #762
derivedSummaryStage2018 |
None | |
Derived Summary Grade 2018 | <BLANK> |
NAACCR #1975
derivedSummaryGrade2018 |
None |